MEX3A is a diagnostic, independent prognostic biomarker and a promising therapeutic target in glioblastoma
{{output}}
Objective: Gliomas are the most common malignant brain tumors with a poor prognosis. Despite advances in molecular profiling, no targeted therapies significantly improve survival. Recently, it has been demonstrated that high expr... ...